The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.

Patients were randomized to undergo treatment with the new-look AnchorMan or the Watchman 2.5. A follow-up study comparing the AnchorMan to the Watchman FLX and FLX Pro devices is already planned.

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.

"Data should simply be a measure of a broader organizational objective," one expert explained. "When the data becomes the goal, that's where organizations can get into trouble."

The long-lasting implant could help patients benefit from semaglutide therapy without needing to take the drug on a daily basis. 

The daily polypill was also associated with improved drug adherence, according to new research out of UT Southwestern.

Today's sophisticated mapping systems allow clinicians to visualize VT circuits with unprecedented detail.

Lisa Nee, MD, a former interventional cardiologist and public policy advisor, has officially joined a crowded mayoral race.